Pharmacology & ToxicologybioRxivPreprint
A non-retinoid triazolopyrimidine RBP4 antagonist for the treatment of Stargardt disease
K. Alison Rinderspacher, András Váradi, Bóglárka Rácz…·Konstantin E. Petrukhin
This paper describes a non-retinoid RBP4 antagonist, AKR-XI-85, that reduces lipofuscin accumulation in a mouse model of Stargardt disease.
DOI 10.64898/2026.09.14.751502